Table 3.
Index | Group | Model 1 | Model 2 | Model 3 |
---|---|---|---|---|
β (95% CI) | β (95% CI) | β (95% CI) | ||
Total femur BMD | Q1: 0.15–11.25 gm/day | Reference (0) | Reference (0) | Reference (0) |
Q2: 11.30–15.90 gm/day | 0.0153 (−0.0038, 0.0343) | 0.0106 (−0.0057, 0.0270) | 0.0021 (−0.0129, 0.0172) | |
Q3: 15.95–22.05 gm/day | 0.0199 (0.0009, 0.0389) | 0.0187 (0.0023, 0.0352) | 0.0141 (−0.0016, 0.0297) | |
Q4: 22.10–95.20 gm/day | 0.0340 (0.0150, 0.0530) | 0.0132 (−0.0037, 0.0300) | 0.0131 (−0.0041, 0.0304) | |
Femoral neck BMD | Q1: 0.15–11.25 gm/day | Reference (0) | Reference (0) | Reference (0) |
Q2: 11.30–15.90 gm/day | 0.0018 (−0.0161, 0.0197) | 0.0022 (−0.0132, 0.0176) | −0.0058 (−0.0206, 0.0090) | |
Q3: 15.95–22.05 gm/day | 0.0059 (−0.0120, 0.0237) | 0.0129 (−0.0026, 0.0284) | 0.0072 (−0.0082, 0.0227) | |
Q4: 22.10–95.20 gm/day | 0.0198 (0.0019, 0.0377) | 0.0131 (−0.0028, 0.0289) | 0.0093 (−0.0077, 0.0263) | |
Trochanter BMD | Q1: 0.15–11.25 gm/day | Reference (0) | Reference (0) | Reference (0) |
Q2: 11.30–15.90 gm/day | 0.0147 (−0.0007, 0.0302) | 0.0117 (−0.0021, 0.0256) | 0.0042 (−0.0087, 0.0170) | |
Q3: 15.95–22.05 gm/day | 0.0189 (0.0035, 0.0343) | 0.0183 (0.0044, 0.0323) | 0.0147 (0.0013, 0.0281) | |
Q4: 22.10–95.20 gm/day | 0.0247 (0.0092, 0.0401) | 0.0111 (−0.0032, 0.0253) | 0.0117 (−0.0030, 0.0265) | |
Intertrochanter BMD | Q1: 0.15–11.25 gm/day | Reference (0) | Reference (0) | Reference (0) |
Q2: 11.30–15.90 gm/day | 0.0148 (−0.0079, 0.0375) | 0.0084 (−0.0113, 0.0281) | −0.0006 (−0.0189, 0.0177) | |
Q3: 15.95–22.05 gm/day | 0.0200 (−0.0026, 0.0427) | 0.0170 (−0.0029, 0.0368) | 0.0114 (−0.0076, 0.0305) | |
Q4: 22.10–95.20 gm/day | 0.0379 (0.0152, 0.0606) | 0.0110 (−0.0093, 0.0314) | 0.0113 (−0.0097, 0.0323) |
Bold variables indicate P-value < 0.05. Model 1: unadjusted model; Model 2: age, sex, and race were adjusted; Model 3: age, sex, race, education level, income level, BMI, smoking status, alcohol consumption, hypertension, diabetes, blood calcium level, serum 25-hydroxyvitamin D, RA, cancer, use of glucocorticoid, family history of osteoporosis, previous fractures, physical activity level, calcium intake level, and vitamin D intake level were adjusted. BMD, bone mineral density; CI, confidence interval.